Vaccines in Veterinary Medicine: A Brief Review of History and Technology

Veterinary Clinics of North America - Small Animal Practice

Volumn 40, Issue 3, 2010, Pages 381-392

  McVey, Scott ^a   Shi, Jishu ^b  

^a UNIVERSITY OF NEBRASKA LINCOLN   (United States)

^b KANSAS STATE UNIVERSITY   (United States)

Author keywords

Immunization; Vaccination efficacy; Vaccine; Vaccine technology

Indexed keywords

ADENOVIRUS VACCINE; ANTHRAX VACCINE; BCG VACCINE; BORDETELLA BRONCHISEPTICA VACCINE; CALICIVIRUS VACCINE; CATTLE PLAGUE VACCINE; CORONA VIRUS VACCINE; DISTEMPER VACCINE; FELINE PANLEUKOPENIA VIRUS VACCINE; FOOT AND MOUTH DISEASE VACCINE; HERPES VACCINE; LEPTOSPIROSIS VACCINE; LYME DISEASE VACCINE; PARAINFLUENZA VACCINE; PARVOVIRUS VACCINE; RABIES VACCINE; SMALLPOX VACCINE; TYPHOID VACCINE; UNCLASSIFIED DRUG; VACCINE;

ADENOVIRUS INFECTION; ANTHRAX; BORDETELLA BRONCHISEPTICA INFECTION; CALICIVIRUS INFECTION; CANINE DISTEMPER; CORONAVIRUS INFECTION; DRUG EFFICACY; DRUG POTENCY; DRUG SAFETY; DRUG USE; FELINE PANLEUKOPENIA; FOOT AND MOUTH DISEASE; HERPES VIRUS INFECTION; HUMAN; IMMUNIZATION; IMMUNOGENICITY; INFECTION CONTROL; INFECTION PREVENTION; LEPTOSPIROSIS; LYME DISEASE; NONHUMAN; PARAINFLUENZA VIRUS INFECTION; PARVOVIRUS INFECTION; RABIES; REVIEW; RINDERPEST; SMALLPOX; TUBERCULOSIS; TYPHOID FEVER; VACCINATION; VACCINE PRODUCTION; VETERINARY MEDICINE;

ANIMAL DISEASES; ANIMALS; ANIMALS, DOMESTIC; VACCINATION; VETERINARY MEDICINE;

EID: 77952755708     PISSN: 01955616     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cvsm.2010.02.001     Document Type: Review

References (34)

1. Needham J. China and the origins of immunology. East Horiz 1980, 19:6-12.
2. Lombard M., Pastoret P.P., Moulin A.M. A brief history of vaccines and vaccination. Rev Sci Tech 2007, 26:29-48.
3. Jenner E. An inquiry into the causes and effects of the variolae vaccinae, a disease discovered in some of the western counties of England. Particularly Gloucestershire, and known by the name of The Cow Pox 1798, Samson Low, London, p. 75.
4. Pasteur L. Comptes rendus de l'Academie des Sciences 1880, 91:673-680. [in French].
5. Pasteur L., Chamberland C., Roux E. Comptes rendus de l'Academie des Sciences 1881, 92:1378-1383. [in French].
6. Pasteur L. Comptes rendus de l'Academie des Sciences 1885, 101:765-773. [in French].
7. Salmon D.E., Smith T. On a new method of producing immunity from contagious diseases. American Veterinary Review 1886, 10:63-69.
8. Ramon G. Sur la toxine et l'anatoxine diphtheriques. Pouvir floculant et proprietes immunoantes. Ann Inst Pasteur 1924, 38:1-10. [in French].
9. Waldmann D., Kobe K., Pyl G. Die aktive immunisierung des Rindes gegen Maul und Klauenseuche. Orig. Zentralbl Bakteriol 1937, 401. [in German].
10. Horzinek M.C., Thiry E. Vaccines and vaccination: the principles and the polemics. J Feline Med Surg 2009, 11:530-537.
11. Schultz R.D. Duration of immunity for canine and feline vaccines: a review. Vet Microbiol 2006, 117:75-79.
12. Day M.J., Horzinek M.C., Schultz R.D. Guidelines for the vaccination of dogs and cats. Compiled by the Vaccination Guidelines Group (VGG) of the World Small Animal Veterinary Association (WSAVA). J Small Anim Pract 2007, 48:528-541.
13. Patel J.R., Heldens J.G. Review of companion animal viral diseases and immunoprophylaxis. Vaccine 2009, 27:491-504.
14. Davis-Wurzler G.M. Current vaccination strategies in puppies and kittens. Vet Clin North Am Food Anim Pract 2006, 36:607-640. vii.
15. Warrell M.J. Emerging aspects of rabies infection: with a special emphasis on children. Curr Opin Infect Dis 2008, 21:251-257.
16. Zadoks R.N., Schukken Y.H. Use of molecular epidemiology in veterinary practice. Vet Clin North Am Food Anim Pract 2006, 22:229-261.
17. Rupprecht C.E., Hanlon C.A., Hemachudha T. Rabies re-examined. Lancet Infect Dis 2002, 2:327-343.
18. Plotkin S.A. Vaccines: correlates of vaccine-induced immunity: an official publication of the Infectious Diseases Society of America. Clin Infect Dis 2008, 47:401-409.
19. Boni M.F. Vaccination and antigenic drift in influenza. Vaccine 2008, 26(Suppl 3):C8-14.
20. Jas D., Aeberlé C., Lacombe V., et al. Onset of immunity in kittens after vaccination with a non-adjuvanted vaccine against feline panleucopenia, feline calicivirus and feline herpesvirus. Vet J 2009, 182:86-93.
21. Lappin M.R., Veir J., Hawley J. Feline panleukopenia virus, feline herpesvirus-1, and feline calicivirus antibody responses in seronegative specific pathogen-free cats after a single administration of two different modified live FVRCP vaccines. J Feline Med Surg 2009, 11:159-162.
22. Tham K.M., Studdert M.J. Antibody and cell-mediated immune responses to feline herpesvirus 1 following inactivated vaccine and challenge. Zentralbl Veterinarmed B 1987, 34:585-597.
23. Scott F.W., Geissinger C.M. Long-term immunity in cats vaccinated with an inactivated trivalent vaccine. Am J Vet Res 1999, 60:652-658.
24. Rimmelzwaan G.F., McElhaney J.E. Correlates of protection: novel generations of influenza vaccines. Vaccine 2008, 26(Suppl 4):D41-D44.
25. Panchanathan V., Chaudhri G., Karupiah G. Correlates of protective immunity in poxvirus infection: where does antibody stand?. Immunol Cell Biol 2008, 86:80-86.
26. Vecht U., Wisselink H.J., Jellema M.L., et al. Identification of two proteins associated with virulence of Streptococcus suis type 2. Infect Immun 1991, 59:3156-3162.
27. Garlapati S., Facci M., Polewicz M., et al. Strategies to link innate and adaptive immunity when designing vaccine adjuvants. Vet Immunol Immunopathol 2009, 128:184-191.
28. Mutwiri G., Gerdts V., Lopez M., et al. Innate immunity and new adjuvants. Rev Sci Tech 2007, 26:147-156.
29. Schijns V.E., Degen W.G. Vaccine immunopotentiators of the future. Clin Pharmacol Ther 2007, 82:750-755.
30. Poland G.A., Ovsyannikova I.G., Jacobson R.M. Personalized vaccines: the emerging field of vaccinomics. Expert Opin Biol Ther 2008, 8:1659-1667.
31. Jagusztyn-Krynicka E.K., Dadlez M., Grabowska A., et al. Proteomic technology in the design of new effective antibacterial vaccines. Expert Rev Proteomics 2009, 6:315-330.
32. Tacket C.O. Plant-based oral vaccines: results of human trials. Curr Top Microbiol Immunol 2009, 332:103-117.
33. Bae K., Choi J., Jang Y., et al. Innovative vaccine production technologies: the evolution and value of vaccine production technologies. Arch Pharm Res 2009, 32:465-480.
34. Poland G.A., Jacobson R.M., Ovsyannikova I.G. Trends affecting the future of vaccine development and delivery: the role of demographics, regulatory science, the anti-vaccine movement, and vaccinomics. Vaccine 2009, 27:3240-3244.